CONDUIT PHARMACEUTICALS INC (CDT) Stock Balance Sheet
NASDAQ:CDT - Nasdaq - US20678X2053 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.13M | 554.00K | 4.23M | 300.00K | 0.00 | |||
| Receivables | N/A | 489.00K | N/A | N/A | N/A | |||
| Other Current Assets | 3.82M | 1.67M | 1.50M | 300.00K | 100.00K | |||
| Total Current Assets | 5.95M | 2.71M | 5.73M | 600.00K | 100.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 275.00K | 303.00K | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | 0.00 | 5.00K | 0.00 | |||
| Other Non-Current Assets | 1.10M | 1.18M | 1.49M | 136.90M | 100.00K | |||
| Total Non-Current Assets | 1.37M | 1.48M | 1.49M | -595.00K | N/A | |||
| TOTAL ASSETS | 7.32M | 4.19M | 7.22M | 5.00K | 0.00 | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 2.66M | 7.08M | 800.00K | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 150.00K | 185.00K | N/A | N/A | |||
| Accrued Expenses | 1.17M | 2.08M | 601.00K | 2.58M | 2.23M | |||
| Accounts Payable | 714.00K | 1.43M | 215.00K | N/A | N/A | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 1.40M | 0.00 | |||
| Total Current Liabilities | 4.55M | 10.74M | 1.80M | 3.99M | 2.23M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 2.01M | 749.00K | |||
| Other Non-Current Liabilities | 86.00K | 245.00K | 5.88M | 4.08M | 2.96M | |||
| Total Non-Current Liabilities | 86.00K | 245.00K | 5.88M | 6.09M | 3.71M | |||
| TOTAL LIABILITIES | 4.63M | 10.99M | 7.68M | 10.08M | 5.94M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -34.25M | -29.10M | -11.30M | -10.76M | -5.88M | |||
| Additional Paid In Capital | 36.57M | 21.88M | 10.42M | 0.00 | 0.00 | |||
| Common Shares | 19.00K | 14.00K | 7.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 346.00K | 414.00K | 411.00K | 688.00K | -65.00K | |||
| Shares Outstanding | 634.10K | 1.38M | 73.83M | 73.83M | 73.83M | |||
| Tangible Book Value per Share | 4.24 | -73.58 | -0.01 | -0.14 | -0.08 | |||
| Total Shareholders' Equity | 2.69M | -6.79M | -457.00K | -10.08M | -5.94M | |||
| TOTAL LIABILITIES AND EQUITY | 7.32M | 4.19M | 7.22M | 5.00K | 0.00 | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | -0.20 | -0.13 | |||
| Current Ratio | 1.31 | 0.25 | 3.18 | 0.15 | 0.04 | |||
| Return On Assets (ROA) | -264.94% | -424.56% | -7.41% | -97740.00% | N/A | |||
| Return On Equity (ROE) | -721.85% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21